Correction to: Real‑world experience with dalbavancin therapy in gram‑positive skin and soft tissue infection, bone and joint infection

Selma Tobudic; Christina Forstner; Heinz Burgmann; Heimo Lagler; Christoph Steininger; Ludwig Traby; Mathias G Vossen; Stefan Winkler; Florian Thalhammer

doi:10.1007/s15010-019-01372-9

Correction to: Real‑world experience with dalbavancin therapy in gram‑positive skin and soft tissue infection, bone and joint infection

Infection. 2020 Feb;48(1):149. doi: 10.1007/s15010-019-01372-9.

Authors

Selma Tobudic¹, Christina Forstner^{2

3}, Heinz Burgmann², Heimo Lagler², Christoph Steininger², Ludwig Traby², Mathias G Vossen², Stefan Winkler², Florian Thalhammer²

Affiliations

¹ Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. selma.tobudic@meduniwien.ac.at.
² Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
³ Institute Infectious Diseases and Infection Control, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.

PMID: 31741186
DOI: 10.1007/s15010-019-01372-9

Abstract

The original version of this article unfortunately contained a mistake. The presentation of Fig. 1 was incorrect. The corrected figure is given below.

Publication types

Published Erratum